Interleukin 8 activity influences the efficacy of adenoviral oncolytic immunotherapy in cancer patients.

Taipale, Kristian; Tähtinen, Siri; Havunen, Riikka; Koski, Anniina; Liikanen, Ilkka; Pakarinen, Päivi; Koivisto-Korander, Riitta; Kankainen, Matti; Joensuu, Timo; Kanerva, Anna; Hemminki, Akseli

Taipale, Kristian; Tähtinen, Siri; Havunen, Riikka; Koski, Anniina; Liikanen, Ilkka; Pakarinen, Päivi; Koivisto-Korander, Riitta; Kankainen, Matti; Joensuu, Timo; Kanerva, Anna; Hemminki, Akseli.

Afiliação

Taipale K; Cancer Gene Therapy Group, University of Helsinki, Faculty of Medicine, Helsinki, Finland.
Tähtinen S; Cancer Gene Therapy Group, University of Helsinki, Faculty of Medicine, Helsinki, Finland.
Havunen R; Cancer Gene Therapy Group, University of Helsinki, Faculty of Medicine, Helsinki, Finland.
Koski A; Cancer Gene Therapy Group, University of Helsinki, Faculty of Medicine, Helsinki, Finland.
Liikanen I; Department of Neurosurgery, HUCH, Helsinki, Finland.
Pakarinen P; Cancer Gene Therapy Group, University of Helsinki, Faculty of Medicine, Helsinki, Finland.
Koivisto-Korander R; Department of Obstetrics and Gynecology, HUCH, Helsinki, Finland.
Kankainen M; Department of Obstetrics and Gynecology, HUCH, Helsinki, Finland.
Joensuu T; Institute for Molecular Medicine Finland (FIMM), University of Helsinki, Helsinki, Finland.
Kanerva A; Docrates Cancer Center, Helsinki, Finland.
Hemminki A; Cancer Gene Therapy Group, University of Helsinki, Faculty of Medicine, Helsinki, Finland.

Oncotarget ; 9(5): 6320-6335, 2018 Jan 19.

Article em En | MEDLINE | ID: mdl-29464075

Palavras-chave

anti-tumor immunity; cytokines; immunomodulation; neutrophils; oncolytic adenovirus

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: Oncotarget Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Finlândia

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google